Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells

Published:2014-10-06 Issue:29 Volume:34 Page:3871-3880
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Redmond A M,Byrne C,Bane F T,Brown G D,Tibbitts P,O’Brien K,Hill A D K,Carroll J S,Young L S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2014323.pdf

Reference44 articles.

1. Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011; 378: 771–784.

2. Onate SA, Tsai SY, Tsai MJ, O'Malley BW . Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270: 1354–1357.

3. Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB et al. Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence. Clin Cancer Res 2009; 15: 2098–2106.

4. Qin L, Liu Z, Chen H, Xu J . The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res 2009; 69: 3819–3827.

5. McBryan J, Theissen SM, Byrne C, Hughes E, Cocchiglia S, Sande S et al. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. Cancer Res 2012; 72: 548–559.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liriodendrin stimulates proliferation and milk protein synthesis of mammary epithelial cells via the PI3K-DDX18 signaling;In Vitro Cellular & Developmental Biology - Animal;2024-08-12

2. Deciphering the roles of the HMGB family in cancer: Insights from subcellular localization dynamics;Cytokine & Growth Factor Reviews;2024-08

3. Impact of Rare Non-coding Variants on Human Diseases through Alternative Polyadenylation Outliers;2024-03-07

4. Potential prognostic biomarkers of hepatocellular carcinoma based on 4D label-free quantitative proteomics analysis pilot investigation;The International Journal of Biological Markers;2023-11-13

5. ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer;Epigenetics;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3